Zobrazeno 1 - 4
of 4
pro vyhledávání: '"P. I. Miklush"'
Autor:
K. V. Zhdanov, O. V. Mal’cev, K. V. Kozlov, P. I. Miklush, E. V. Peredel’skij, S. N. Sidorchuk, Yu. A. Kravchuk, A. S. Sigidaev, V. G. Dedkov, A. A. Konushkaliev
Publikováno v:
Журнал инфектологии, Vol 15, Iss 2, Pp 156-161 (2023)
Crimean haemorrhagic fever (Crimean-Congo haemorrhagic fever) – an important public health problem due to the wide geographical spread, the ability to cause epidemic outbreaks of disease and high mortality. Evidence that human infection in some cas
Externí odkaz:
https://doaj.org/article/134a3c15959f429683bf19181d5c6eba
Publikováno v:
Журнал инфектологии, Vol 13, Iss 4, Pp 57-65 (2021)
An important area of effective control of the COVID-19 pandemic is the study of the pathogenetic features of SARSCoV-2 infection, including those based on the assessment of the state of the microbiota and intestinal permeability.Purpose: To study the
Externí odkaz:
https://doaj.org/article/2c92becb241c4b5fa8cb7b33b822285c
Autor:
E. V. Kryukov, K. V. Zhdanov, K. V. Kozlov, V. Yu. Kravtsov, O. V. Mal’tsev, V. S. Sukachev, P. I. Miklush, M. O. Sokolova, V. V. Sharabkhanov, R. I. Glushakov, V. V. Dvoryanchikov, R. R. Achba, D. V. Trishkin, I. I. Azarov
Publikováno v:
Журнал инфектологии, Vol 13, Iss 2, Pp 5-13 (2021)
Given that COVID-19 is a global public health problem and that almost all countries in the world have been severely affected by the COVID-19 pandemic, research is being actively pursued to better understand the effects of the virus on human cells. Ho
Externí odkaz:
https://doaj.org/article/03a9d92a600b402690bd86d2fbe8d0e7
Autor:
K. V. Zhdanov, K. V. Kozlov, P. I. Miklush, N. I. Lvov, O. V. Maltsev, V. V. Sharabkhanov, I. M. Yurkaev, V. F. Krumgoltz, R. Ju. Kuznetsova, K. S. Ivanov, Ju. I. Lyashenko, K. D. Kicherov, E. B. Masalov
Publikováno v:
Clinical Medicine (Russian Journal). 100:185-192
Monoclonal antibodies IL-6 inhibitors (olokizumab) and IL-6 receptor inhibitors (tocylisumab, levilimab) are most widely used for proactive anti-inflammatory therapy in patients with COVID-19. A decrease in blood oxygen saturation after 12–72 hours
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65a598c3d68aab90f664b13911ba2e41
https://doi.org/10.30629/0023-2149-2022-100-4-5-185-192
https://doi.org/10.30629/0023-2149-2022-100-4-5-185-192